Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0800
0.00 (0.00%)
Mar 18, 2026, 3:04 PM AEST
Microba Life Sciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -19.75 | -14.94 | -19.94 | -12.68 | -11.47 | -7.52 |
Depreciation & Amortization | 2.34 | 3.03 | 2.87 | 1.64 | 1.15 | 0.83 |
Other Amortization | 2.11 | 1.4 | - | - | 0.39 | 0.39 |
Loss (Gain) From Sale of Assets | 0 | 0 | 0 | 0.02 | 0.02 | - |
Stock-Based Compensation | 1.07 | 0.81 | 0.69 | 0.42 | 0.64 | 0.56 |
Provision & Write-off of Bad Debts | -0.06 | - | - | - | -0.17 | - |
Other Operating Activities | -1.64 | -5.67 | -0.18 | -0.18 | -0.76 | -0.15 |
Change in Accounts Receivable | -0.12 | 3.99 | -0.01 | -3.81 | -1.77 | -1.03 |
Change in Inventory | -0.49 | -0.26 | -0.31 | -0.28 | 0.15 | -0.17 |
Change in Accounts Payable | 0.63 | -0.25 | 0.21 | 2.11 | 1.37 | 0.45 |
Change in Unearned Revenue | -0.07 | -0.35 | 0.47 | 0.42 | -0.23 | 0.03 |
Change in Income Taxes | 0.01 | 0.01 | 0 | 0.01 | - | - |
Change in Other Net Operating Assets | 0.41 | 0.47 | 0.71 | -0.06 | 0.23 | -0.57 |
Operating Cash Flow | -15.05 | -12.01 | -15.57 | -12.39 | -10.45 | -7.18 |
Capital Expenditures | -0.34 | -0.33 | -1.49 | -0.55 | -1.64 | -0.25 |
Sale of Property, Plant & Equipment | 0.06 | - | - | - | 0.01 | - |
Cash Acquisitions | - | - | -9.57 | - | - | - |
Sale (Purchase) of Intangibles | -3.17 | -2.57 | -2.89 | -2.49 | -0.24 | -0.43 |
Investment in Securities | 0.07 | 0.07 | - | - | - | - |
Other Investing Activities | - | - | - | 0.04 | 0.13 | 0.1 |
Investing Cash Flow | -3.39 | -2.83 | -13.95 | -3 | -1.73 | -0.57 |
Short-Term Debt Issued | - | - | - | 0.48 | 0.43 | - |
Long-Term Debt Issued | - | 1.71 | 0.49 | - | - | - |
Total Debt Issued | 0.41 | 1.71 | 0.49 | 0.48 | 0.43 | - |
Short-Term Debt Repaid | - | - | - | -0.48 | -0.22 | - |
Long-Term Debt Repaid | - | -1.78 | -1.2 | -0.55 | -0.33 | -0.36 |
Total Debt Repaid | -1.78 | -1.78 | -1.2 | -1.03 | -0.55 | -0.36 |
Net Debt Issued (Repaid) | -1.37 | -0.08 | -0.71 | -0.55 | -0.13 | -0.36 |
Issuance of Common Stock | 14.1 | 6.05 | 20.36 | 17.83 | 31.25 | 15.14 |
Other Financing Activities | -0.38 | -0.38 | -1.26 | -0.6 | -1.9 | -0.95 |
Financing Cash Flow | 12.34 | 5.58 | 18.39 | 16.68 | 29.22 | 13.84 |
Foreign Exchange Rate Adjustments | 0.04 | 0.11 | -0.03 | 0.17 | 0.57 | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - |
Net Cash Flow | -6.05 | -9.15 | -11.15 | 1.46 | 17.6 | 6.08 |
Free Cash Flow | -15.38 | -12.34 | -17.05 | -12.94 | -12.08 | -7.43 |
Free Cash Flow Margin | -103.22% | -78.75% | -141.06% | -238.82% | -257.75% | -199.04% |
Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 |
Cash Interest Paid | 0.15 | 0.18 | 0.07 | 0.06 | 0.06 | 0.02 |
Cash Income Tax Paid | 0.02 | - | 0.03 | 0 | 0.01 | - |
Levered Free Cash Flow | -14.32 | -11.83 | -14.65 | -15.4 | -10.46 | -6.21 |
Unlevered Free Cash Flow | -14.2 | -11.72 | -14.61 | -15.37 | -10.43 | -6.2 |
Change in Working Capital | 0.11 | 3.35 | 0.99 | -1.62 | -0.25 | -1.29 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.